Back

Feature tracking-cardiovascular magnetic resonance to predict major adverse cardiovascular events in patients with cardiac amyloidosis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardiac magnetic resonance insights into amyloidosis imaging Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Marco Maria Dicorato

Bari Polyclinic Consortium University Hospital, Bari (Italy)

7 More presentations in this session

Presentation thumbnail
Multimodality artificial intelligence-based major adverse cardiovascular events prediction in transthyretin amyloid cardiomyopathy patients
Doctor G. Baj (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of atrial fibrosis detected by cardiac magnetic resonance in patients affected by cardiac amyloidosis
Doctor M. Dicorato (Bari, IT)
Abstract Slides Video
Presentation thumbnail
RGAN-Driven T1 Map Synthesis from OS-CMR: a step toward AI-assisted amyloidosis diagnosis
Doctor F. Lotfikazemi (Montreal, CA)
Abstract Slides Video
Presentation thumbnail
Brain amyloid accumulation in patients with transthyretin amyloid cardiomyopathy: a pilot study
Doctor M. Ungericht (Innsbruck, AT)
Abstract Slides Video
Presentation thumbnail
Comparative assessment of CMR-determined extracellular volume metrics in predicting adverse outcomes
Doctor K. Mascherbauer (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac magnetic resonance insights into amyloidosis imaging

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Cardiovascular prognosis in stable patients with amyloidosis: a novel and simple risk score.
thumbnail
Congress Presentation
Advanced echocardiographic and multimodal insights into cardiac amyloidosis: predictors of heart failure and arrhythmic complications in ATTR and al subtypes
thumbnail
Congress Presentation
Impact of the non-invasive diagnostic algorithm on clinical presentation and prognosis in a nationwide multicentric light-chain and transthyretin-related cardiac amyloidosis cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources